Ixazomib
Ixazomib (MLN-2238), is a potent proteasome inhibitor (PI) with potential antineoplastic activity. MNL-2238 is a biologically active form of MLN9708. MLN-2238 has an improved pharmacodynamic profile and antitumor activity compared with bortezomib in both OCI-Ly10 and PHTX22L models.
Product Specifications
Shipping Conditions
Gel Pack
Storage Conditions
-20ºC
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9460080-01 0.1 mL
VE Cadherin Polyclonal Antibody Cy3 Conjugated
Sign In for Pricing
View Details 
MBS9460080-02 5x 0.1 mL
VE Cadherin Polyclonal Antibody Cy3 Conjugated
Sign In for Pricing
View Details 
BNC401100-100 1x 100 µL
Cytokeratin, pan (KRTL/1077 + KRTH/1076), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details